Skip to content

Single blinded cross over trial of two, versus multiple, injections of Botulinum A (Dysport), into the gastrocnemius muscle of children with cerebral palsy, to compare efficacy and discomfort of either method.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN24558210
Enrollment
Unknown
Registered
2004-09-30
Start date
2003-12-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous System Diseases: Cerebral palsy Nervous System Diseases Cerebral palsy

Interventions

Randomised Controlled Trial. Children are recruited to the study and consent is signed by themselves and/or their carers. They are randomised to group A or group B. Group A: Proceed first to single

Sponsors

Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 20, 4-12 year old children. Boys and girls with cerebral palsy (hemiplegia and diplegia)

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

MeasureTime frame
1. Efficacy of Botulinum toxin injection to that muscle, as assessed by observational gait scale, before at 4 weeks and at 12 weeks 2. The discomfort at the time of injection

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026